Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel

  • Technology appraisal guidance
  • TA391
  • Published: 
  • Last updated: 

History

Documents created during the development process.

Expected publication

Final appraisal determination

Draft guidance

Invitation to participate

Draft scope documents

Appeal

Final appraisal determination

Draft guidance: 1

Invitation to participate

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final scope

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): comments table

Prostate cancer (hormone relapsed, metastatic) - cabazitaxel (after docetaxel): final matrix